The use of selective serotonin receptor inhibitors (SSRIs) is not associated with increased risk of endoscopy-refractory bleeding, rebleeding or mortality in peptic ulcer bleeding.

Stig Borbjerg LaursenG I LeontiadisA J StanleyJ HallasO B Schaffalitzky de Muckadell

Published in: Alimentary pharmacology & therapeutics (2017)

According to our data, treatment with SSRIs does not influence the risk of endoscopy-refractory bleeding, rebleeding or 30-day mortality in peptic ulcer bleeding.

Keyphrases

atrial fibrillation
cardiovascular events
risk factors
small bowel
type diabetes
electronic health record
cardiovascular disease
big data
machine learning
artificial intelligence
binding protein
data analysis